> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Breakthrough Status for Breast Cancer Imager
- URL: https://www.fdaweb.com/breakthrough-status-for-breast-cancer-imager/
- Published: 2021-04-16T12:00:00.000Z
- Updated: 2026-09-14T16:55:14.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5149132

FDA has granted Perimeter Medical Imaging AI a breakthrough device designation for its Optical Coherence Tomography Imaging System coupled with ImgAssist AI. The device is designed to offer advantages over existing alternatives for intra-operative evaluation of margins during breast cancer lumpectomy, according to the company. Perimeter says it is advancing its proprietary, next-gen artificial intelligence technology and machine learning tools through its ATLAS AI project, which has been awarded a $7.4 million grant by the Cancer Prevention and Research Institute of Texas, a state body funding cancer research.